Investments accounted for using the equity method (Tables)

12 Months Ended

Dec. 31, 2025

Investments accounted for using the equity method

Schedule of investment in Hepalys is accounted for using the equity method of accounting

	December 31,		December 31,		December 31,
(in thousands of euros)	2023		2024		2025
Intangible assets	20,278		16,984		12,729
Total non-current assets	20,278		16,984		12,729
Other current assets	44		81		102
Cash and cash equivalents	1,082		1,785		81
Total current assets	1,126		1,866		183
Deferred assets	41		2		—
Total assets	21,444		18,851		12,912
Capital stock	640		552		489
Capital reserve	22,655		21,489		8,267
Capital surplus-others	—		816		10,259
Earnings brought forward	(178)		(1,089)		(2,745)
Net loss for the period	(1,111)		(3,277)		(3,504)
Treasury Shares	(812)		—		—
Shareholders’ equity	21,194		18,490		12,766
Trade payables	237		353		134
Other current liabilities	13		8		12
Total current liabilities	250		361		146
Total equity and liabilities	21,444		18,851		12,912
Opening net assets	22,645		21,122		18,368
Loss for the period(1)	(879)		(3,277)		(3,816)
Other comprehensive income	247		(920)		(1,786)
Capital variations	(819)		1,566		—
Closing net assets	21,194		18,490		12,766
Group’s share in %	15	%	15	%	15	%
(in thousands of euros)
Group’s share	3,267		2,707		1,869
Elimination of unrealized profit on downstream sales	(1,881)		(1,604)		(1,378)
Goodwill	38		37		37
Carrying amount	1,425		1,139		527

⁽¹⁾Refer to Note 23 – Share of net profit (loss) - equity method